NDC Package 0067-6297-01 Lamisil AT

Terbinafine Hydrochloride Aerosol, Spray Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0067-6297-01
Package Description:
125 mL in 1 CAN
Product Code:
Proprietary Name:
Lamisil AT
Non-Proprietary Name:
Terbinafine Hydrochloride
Substance Name:
Terbinafine Hydrochloride
Usage Information:
This medication is used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Terbinafine is an antifungal that works by preventing the growth of fungus.
11-Digit NDC Billing Format:
00067629701
Product Type:
Human Otc Drug
Labeler Name:
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
Dosage Form:
Aerosol, Spray - An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents.
Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    NDA021124
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-07-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0067-6297-01?

    The NDC Packaged Code 0067-6297-01 is assigned to a package of 125 ml in 1 can of Lamisil AT, a human over the counter drug labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The product's dosage form is aerosol, spray and is administered via topical form.

    Is NDC 0067-6297 included in the NDC Directory?

    Yes, Lamisil AT with product code 0067-6297 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on March 07, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0067-6297-01?

    The 11-digit format is 00067629701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20067-6297-015-4-200067-6297-01